References
- Sueblinvong T, Taechakraichana N, Phupong V. Prevalence of climacteric symptoms according to years after menopause. J Med Assoc Thai 2001;84:1681–91
- Burton WN, Pransky G, Conti DJ, Chen CY, Edington DW. The association of medical conditions and presenteeism. J Occup Environ Med 2004;46:S38–45
- Ledesert B, Ringa V, Breart G. Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas 1994;20:113–20
- Women and Sleep Poll. National Sleep Foundation, 1998. at www.sleepfoundation.org/publications/1998womenpoll.cfm.)
- Moe KE. Hot flashes and sleep in women. Sleep Med Rev 2004; 8:487–97
- Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003;167:1181–5
- Dennerstein L, Guthrie JR, Clark M, Lehert P, Henderson VW. A population-based study of depressed mood in middle-aged, Australian-born women. Menopause 2004;11:563–8
- Shepherd JE. Effects of estrogen on congnition mood, and degenerative brain diseases. J Am Pharm Assoc (Wash) 2001; 41:221–8
- Ozkaya E, Cakir E, Kara F, et al. Impact of hot flashes and night sweats on carotid intima-media thickness and bone mineral density among postmenopausal women. Int J Gynaecol Obstet 2011;113:235–8
- Sturdee DW, Pines A, Archer DF, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14: 302–20
- Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
- Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523–34
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
- Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial. JAMA 2003; 289:2673–84
- Cardini F, Lesi G, Lombardo F, van der Sluijs C. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health 2010;10:7
- Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003;10:507–15
- Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 2003;10:465–76
- Nuntanakorn P, Jiang B, Einbond LS, et al. Polyphenolic constituents of Actaea racemosa. J Nat Prod 2006;69: 314–18
- Powell SL, Godecke T, Nikolic D, et al. In vitro serotonergic activity of black cohosh and identification of N(omega)- methylserotonin as a potential active constituent. J Agric Food Chem 2008;56:11718–26
- Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661–70
- Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer C, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005;51:397–404
- Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005;105:1074–83
- Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(Suppl 1):S67–77
- Alder E. The Blatt-Kupperman menopausal index: a critique. Maturitas 1998;29:19–24
- Saghaei M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol 2004;4:26
- Pongpatiroj A, Sripramote M, Wanitwanathong G. Effects of hormone replacement therapy on the quality of life in postmenopausal women. Vajira Med J 2001;45:1–11
- Wuttke W, Seidlova-Wuttke D. News about Black cohosh. Maturitas 2012;71:92–3
- Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006;24:2836–41
- Geller SE, Shulman LP, van Breemen RB, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156–66
- Angsuwathana S, Tanmahasamut P, Rattanachaiyanont M, et al. Serum follicle stimulating hormone and estradiol in peri/ postmenopausal women attending Siriraj Menopause Clinic: a retrospective study. J Med Assoc Thai 2006;89:1101–8
- Sievert LL, Flanagan EK. Geographical distribution of hot flash frequencies: considering climatic influences. Am J Phys Anthropol 2005;128:437–43